14.28
1.14%
-0.165
Tactile Systems Technology Inc stock is currently priced at $14.28, with a 24-hour trading volume of 127.95K.
It has seen a -1.14% decreased in the last 24 hours and a -7.24% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $14.37 pivot point. If it approaches the $14.12 support level, significant changes may occur.
Previous Close:
$14.44
Open:
$14.54
24h Volume:
127.95K
Market Cap:
$339.17M
Revenue:
$274.42M
Net Income/Loss:
$28.52M
P/E Ratio:
555.45
EPS:
0.0257
Net Cash Flow:
$33.37M
1W Performance:
-0.17%
1M Performance:
-7.24%
6M Performance:
+10.74%
1Y Performance:
-23.83%
Tactile Systems Technology Inc Stock (TCMD) Company Profile
Name
Tactile Systems Technology Inc
Sector
Industry
Phone
612-355-5100
Address
1331 Tyler Street NE, Suite 200, Minneapolis
Tactile Systems Technology Inc Stock (TCMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-13-20 | Upgrade | Oppenheimer | Perform → Outperform |
Oct-22-19 | Initiated | Oppenheimer | Perform |
Aug-07-19 | Upgrade | BTIG Research | Neutral → Buy |
Jun-13-19 | Initiated | Dougherty & Company | Buy |
Jan-02-19 | Upgrade | Northland Capital | Under Perform → Market Perform |
Jun-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
Feb-27-18 | Downgrade | Northland Capital | Outperform → Market Perform |
Dec-08-17 | Initiated | Sidoti | Neutral |
Nov-09-17 | Upgrade | BTIG Research | Neutral → Buy |
Oct-12-17 | Initiated | Guggenheim | Buy |
View All
Tactile Systems Technology Inc Stock (TCMD) Latest News
Tactile Systems Technology (TCMD) Rises But Trails Market: What Investors Should Know
Zacks Investment Research
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Tactile Systems Technology (TCMD) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks Investment Research
Tactile Systems Technology and ESCO Technologies have been highlighted as Zacks Bull and Bear of the Day
Zacks Investment Research
Bull Of The Day: Tactile Systems Technology (TCMD)
Zacks Investment Research
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
GlobeNewswire Inc.
Tactile Systems Technology Inc Stock (TCMD) Financials Data
Tactile Systems Technology Inc (TCMD) Revenue 2024
TCMD reported a revenue (TTM) of $274.42 million for the quarter ending December 31, 2023, a +11.20% rise year-over-year.
Tactile Systems Technology Inc (TCMD) Net Income 2024
TCMD net income (TTM) was $28.52 million for the quarter ending December 31, 2023, a +259.60% increase year-over-year.
Tactile Systems Technology Inc (TCMD) Cash Flow 2024
TCMD recorded a free cash flow (TTM) of $33.37 million for the quarter ending December 31, 2023, a +914.72% increase year-over-year.
Tactile Systems Technology Inc (TCMD) Earnings per Share 2024
TCMD earnings per share (TTM) was $1.1957 for the quarter ending December 31, 2023, a +234.35% growth year-over-year.
Tactile Systems Technology Inc Stock (TCMD) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Burns Kristie | Sr. VP Mktg & Clinical Affairs |
Feb 29 '24 |
Sale |
15.25 |
243 |
3,706 |
63,389 |
REUVERS DANIEL L. | President and CEO |
Feb 27 '24 |
Sale |
15.60 |
4,689 |
73,148 |
239,423 |
Burns Kristie | Sr. VP Mktg & Clinical Affairs |
Feb 27 '24 |
Sale |
15.58 |
1,091 |
17,001 |
63,632 |
REUVERS DANIEL L. | President and CEO |
Feb 26 '24 |
Sale |
15.81 |
6,239 |
98,645 |
244,112 |
Burns Kristie | Sr. VP Mktg & Clinical Affairs |
Feb 26 '24 |
Sale |
15.90 |
2,015 |
32,049 |
63,512 |
REUVERS DANIEL L. | President and CEO |
Feb 23 '24 |
Sale |
14.85 |
5,378 |
79,853 |
192,321 |
Burns Kristie | Sr. VP Mktg & Clinical Affairs |
Feb 23 '24 |
Sale |
14.80 |
2,249 |
33,278 |
53,765 |
REUVERS DANIEL L. | President and CEO |
Aug 07 '23 |
Sale |
20.53 |
1,062 |
21,808 |
125,653 |
BURKE WILLIAM W | Director |
May 12 '23 |
Sale |
21.86 |
4,400 |
96,184 |
27,773 |
Burns Kristie | Sr. VP Mktg & Clinical Affairs |
May 08 '23 |
Sale |
18.65 |
786 |
14,659 |
36,562 |
About Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers proprietary Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients. It also provides Entré System, a basic pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was founded in 1995 and is headquartered in Minneapolis, Minnesota.
Cap:
|
Volume (24h):